Month: July 2022

UGGC Africa advised Pharmaceutical Institute (PHI) in its acquisition by Kelix Bio, a pan-African biopharmaceutical platform

March 09, 2022 – Casablanca – UGGC Africa has advised Pharmaceutical Institute on its acquisition by KELIX bio, a pan-African biopharmaceutical platform. This investment marks KELIX bio’s first entry into Morocco – an important market in the company’s strategy – at a time when the Kingdom is accelerating the successful rollout of AMO (Assurance Maladie …

UGGC Africa advised Pharmaceutical Institute (PHI) in its acquisition by Kelix Bio, a pan-African biopharmaceutical platform Read More »

UGGC Africa, assists Mirova in the capital opening of Atlas Fruit Company to Mirova’s Land Degradation Neutrality Fund

Paris, July 4, 2022 – UGGC Africa, a leading firm in Africa, has advised Mirova (an affiliate of Natixis Investment Managers), manager of the Land Degradation Neutrality (LDN) impact fund, on the acquisition of a majority stake in Atlas Fruits Company. The Land Degradation Neutrality (LDN) Fund, promoted by the United Nations Convention to Combat …

UGGC Africa, assists Mirova in the capital opening of Atlas Fruit Company to Mirova’s Land Degradation Neutrality Fund Read More »